Sangamo Therapeutics
Clinical trials sponsored by Sangamo Therapeutics, explained in plain language.
-
15-Year watch: tracking gene Therapy's lasting impact on blood disorders
Disease control OngoingThis study is tracking the long-term safety and effectiveness of two gene therapies (BIVV003 and ST-400) for up to 15 years. It follows 8 people who have already received these treatments for severe sickle cell disease or transfusion-dependent beta-thalassemia. The main goal is t…
Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC
-
Scientists track patients for 15 years after groundbreaking transplant cell therapy
Disease control OngoingThis study is tracking the long-term safety of an experimental cell therapy given to kidney transplant patients. The therapy, called CAR-Treg, is designed to help the body accept the new kidney and reduce rejection. Researchers will follow 11 patients for up to 15 years to monito…
Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC